Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
97%
Envelope Glycoprotein
34%
Reverse Transcriptase
31%
Gp120
30%
(I)-envelope
26%
Viral Glycoprotein
19%
Broadly Neutralizing Antibodies
19%
Gp41
14%
Env Trimer
14%
AIDS/HIV
12%
Viral
12%
C-C Chemokine Receptor Type 5 (CCR5)
12%
Trimer
12%
Conformational Change
11%
Conformational Transition
11%
Envelope Glycoprotein Trimer
11%
HIV Entry
10%
Entry Inhibitor
10%
Integrase
9%
Virus Entry
9%
HIV-1 Env
9%
Env Conformation
9%
Simian Immunodeficiency Virus
7%
Virus
7%
Ectodomain
6%
CD4 Receptor
6%
Novel Inhibitors
6%
CD4 Binding
5%
Viral Entry
5%
Trimeric
5%
Neutralizing Antibodies
5%
HIV Infection
5%
Small Molecules
5%
Intermediate State
5%
Virus Envelope
5%
Cell-to-cell Transmission
5%
Regulatory Switch
5%
SERINC5
5%
HIV Vaccine
5%
Host Cell
5%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Glycoprotein
53%
CD4
33%
Human Immunodeficiency Virus
30%
Conformation
22%
Neutralizing Antibody
21%
Reverse Transcriptase
21%
Conformational Transition
16%
Gp41
13%
Viral Entry
13%
Integrase
11%
Peptides
10%
CCR5
10%
Virus
9%
Viral Envelope
8%
T Cell
5%
T-Helper Cell
5%
Spike
5%
Viral Protein
5%
Human Immunodeficiency Virus Infection
5%
Simian Immunodeficiency Virus
5%
Glycosylation
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
49%
Glycoprotein
21%
Reverse Transcriptase
18%
Integrase
11%
Gp41
10%
CD4
10%
Conformation
10%
Human Immunodeficiency Virus
9%
Ectodomain
6%
Neutralizing Antibody
6%
Conformational Change
6%
Small Molecule
5%
Virus Entry
5%